Skip to main content
ConductScienceScienceDex

Ping Mu

NIH Rank #10936
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14536041Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Urology
  • Biochemistry

NIH Funding · FY2024

Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#10,936
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ping Mu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Ping Mu as a PI. Multi-PI records show the full award amount for context.

  • 7R37CA258730-05R37
    Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
    Yale University
    $467K
    award amount
  • 7R01CA292949-02R01
    Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation
    Yale University
    $399.7K
    award amount
  • 7R01CA288820-02R01
    Deciphering the Impact of ZNF397-deficiency in Promoting TET2-driven Epigenetic Rewiring, Lineage Plasticity, and Therapy Resistance in Prostate Cancer
    Yale University
    $397.7K
    award amount
  • 1R01CA288820-01R01
    Deciphering the Impact of ZNF397-deficiency in Promoting TET2-driven Epigenetic Rewiring, Lineage Plasticity, and Therapy Resistance in Prostate Cancer
    UT Southwestern Medical Center
    $8.3K
    award amount
  • 1R01CA292949-01R01
    Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation
    UT Southwestern Medical Center
    $8.2K
    award amount
  • 3R37CA258730-04S1R37
    Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
    UT Southwestern Medical Center
    $3.5K
    award amount
  • 5R37CA258730-04R37
    Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
    UT Southwestern Medical Center
    $1
    award amount

Award organizations

Organizations that administered FY2024 awards listing Ping Mu as a PI.

Yale University
CT
$1.3M
3 grants
UT Southwestern Medical Center
TX
$20K
4 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Yale University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  6. 2025
    R01 Grant Holder

Explore further

Find collaborators for Ping Mu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Ping Mu | NIH Award Records | ConductScience